Schonfeld Strategic Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-66,382	Closed	-$1.83M	–	2662
2021 Q2	$1.83M	Buy	66,382 +34,276	+107%	+$674K	0.02%	745
2021 Q1	$529K	Buy	+32,106	New	+$731K	0.01%	1120
2018 Q3	–	Sell	-20,000	Closed	-$253K	–	1098
2018 Q2	$253K	Buy	+20,000	New	+$242K	0.01%	660

Schonfeld Strategic Advisors's TBIO Position: Q3 2021 in Review

Schonfeld Strategic Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 66,382 shares — an estimated $1.83M sold.

Schonfeld Strategic Advisors first reported a position in TBIO in Q2 2018 and held it in 3 quarters. The position peaked at $1.83M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Schonfeld Strategic Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Schonfeld Strategic Advisors sold 66,382 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.83M.
Schonfeld Strategic Advisors first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
Schonfeld Strategic Advisors's Translate Bio, Inc. Common Stock position peaked at $1.83M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.